French CEOs are stuck on AI. They all repeat the same reassuring phrase: "AI augments humans, it does not replace them." It is a board-meeting anxiolytic.
That sentence avoids three conversations: the restructuring of the middle layers, the redesign of the P&L by function, the redefinition of the internal social contract.
As long as these three conversations are postponed, AI remains a cost center disguised as an innovation center.
The numbers confirm it. 95% of GenAI pilots never reach production (MIT, 2025). 74% of companies show no tangible value from their GenAI investments (BCG, 2024).
This is not a technology problem. It is a problem of executive courage.
This is not a technology problem. It is a problem of executive courage. Hikari Blue · operator note
The question shareholders are sharpening
Meanwhile, shareholders are sharpening a single question. Not "do you have a vision of AI". Too vague. Too easy to dodge.
The real question, the one that separates the executives who will remain from those who will leave, is sharper:
What is your company's target operating margin in 36 months if AI absorbs 30% of the cost of support functions, and what is your capital plan to get there?
CEOs who do not know how to answer with a number, a timetable, and a financing plan will be replaced. Not because they leaned on the augmentation talking point. Because they failed to model the transformation of their own income statement.
The question to bring to the next board
The question to bring to the next board meeting is not "are we ready?".
The question is:
Have you presented this number to your board?
The Hikari Blue team · Austin, May 2026
